A cross-sectional study of clinical and pathological data analyses from patients with anti-CTLA-4/PD-1 colitis demonstrated that CD8+TRMs constituted the majority of activated TRMs in irColitis, with the degree of activation correlating with clinical and endoscopic severity. This evidence concerns the gene CTLA4 and colitis.